Prognostic value of malignant T cell-amplified sequence 1 in head and neck squamous cell carcinoma.
Biomark Med
; 15(17): 1623-1639, 2021 12.
Article
de En
| MEDLINE
| ID: mdl-34704820
ABSTRACT
Aim:
To explore the expression profile and prognostic value of MCTS1 in head and neck squamous cell carcinoma (HNSC). Materials &methods:
This study used the data from TCGA to HNSC database, GEO database and the data and specimens collected from the patients in our hospital to conduct a comprehensive bioinformatic analysis of MCTS1 in HNSC.Results:
MCTS1 was significantly upregulated. MCTS1 mRNA expression level is a potential prognostic biomarker for overall survival and recurrence-free survival. We revealed the potential interactions of MCTS1 with other molecules and potential relationship with ubiquitination, translation initiation and mRNA splicing in HNSC.Conclusion:
MCTS1 was significantly upregulated in primary HNSC. The correlation of MCTS1 with poor prognosis suggested its potential as a prognostic marker for HNSC patients.Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Protéines oncogènes
/
Protéines du cycle cellulaire
/
Carcinome épidermoïde de la tête et du cou
/
Tumeurs de la tête et du cou
Type d'étude:
Prognostic_studies
Limites:
Female
/
Humans
/
Male
/
Middle aged
Langue:
En
Journal:
Biomark Med
Sujet du journal:
BIOQUIMICA
/
MEDICINA
Année:
2021
Type de document:
Article